Allena Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Allena Pharmaceuticals

10/08/2021 23:14

* Allena Pharmaceuticals Inc  ALNA.OQ  reported a quarterly
adjusted loss of 24 cents​​ per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 21 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Allena Pharmaceuticals Inc's reported EPS for the quarter was
a loss of 24 cents​.
* The mean earnings estimate of analysts had risen by about 9.7%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Allena Pharmaceuticals Inc shares had fallen by 24.0% this
quarter and lost 22.8% so far this year.
* The company reported a quarterly loss of $13.97 million.
* Wall Street's median 12-month price target for Allena
Pharmaceuticals Inc is $6.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 10:14 p.m.  ​All
figures in US dollars unless otherwise stated